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11. Abstract  
	  
Introduction: Stroke is the second most common cause of death in the world and 85% of 
strokes are ischemic due to obstruction of blood vessels. This leads to deprivation of oxygen 
and glucose, which causes energy failure and neuronal death. There is an increasing interest 
in developing new therapies for ischemic stroke due to short therapeutic window and lack of 
currently available treatments. Astrocytes provide a major role in brain’s response to 
ischemic injury by providing antioxidant protection, growth factors and glutamate clearance. 
A detailed understanding of astrocyte-neuron interaction can provide valuable therapeutic 
targets. This study aims to use astroglial-neuronal co-cultures to investigate affect of hypoxia 
on interaction between astrocytes and neurons.  
Methods: Primary astrocytes were obtained from mouse newborns and NSCs from E14.5 
mouse embryos. Astrocytes and NSCs were seeded together to develop astroglial-neuronal 
co-cultures, which were incubated in normoxic and hypoxic conditions. Co-cultures were 
characterized using live imagining and immunocytochemistry, quantification of cellular 
motility and relative gene expression of apoptotic (caspase 8) and necroptotic marker 
(MLKL) was performed using live cell tracing and rt-PCR respectively.  
Results: The characterization of co-cultures in hypoxic conditions showed NSCs 
differentiation into unipolar and bipolar neurons and presence of flat and epithelioid 
astrocytes. The average and maximum speed of cells in astroglial-neuronal co-cultures was 
higher in hypoxic conditions, but less than NSCs single culture in normoxia. Relative gene 
expression of caspase 8 was higher than MLKL in both hypoxic and normoxic conditions. 
Discussion: There was better differentiation and survival of NSCs in astroglial-neuronal co-
cultures in hypoxic conditions. This was also reflected in better cellular motility of astroglial-
neuronal co-cultures in hypoxic conditions. Caspase 8 and MLKL exhibited reciprocal 
relationship of expression in both normoxic and hypoxic conditions. Although we observed 
difference in expression of caspase 8 and MLKL in normoxic and hypoxic conditions, more 
samples will be needed to define precise levels of statistical significance of this finding. 
Conclusion: In this work we observed responses of astrocytes and neurons in astroglial-
neuronal co-cultures, which were fairly consistent with what happens in ischemia. More 
studies will be required to characterize and understand observed phenomena in the astroglial-
neuronal co-cultures.   
Key Words: Astrocytes, neuronal stem cells (NSCs), astroglial-neuronal co-cultures, 
hypoxia, cell motility, caspase 8, MLKL, real-time PCR. 
22. Sažetak  
	  
Uvod: Moždani udar je drugi najčešći uzrok smrti u svijetu. U 85% slučajeva se radi o 
ishemijskom moždanom udaru uzrokovanom prekidom protoka krvi, a time glukoze i kisika, 
kroz krvnu žilu, što uzrokuje energetski disbalans i smrt neurona. Trenutno dostupni 
terapijski pristupi mogu se primjeniti u ograničenom vremenskom razdoblju te stoga postoji 
potreba za novim pristupima u liječenju ishemijskog moždanog udara. Astrociti imaju važnu 
ulogu u odgovoru na ishemiju mozga jer pružaju antioksidativnu zaštitu, proizvode faktore 
rasta te uklanjaju glutamat. Bolje poznavanje interakcija između neurona i astrocita moglo bi 
iznjedriti neke nove terapijske mete. Cilj ovog rada je bio uspostaviti kokulture astrocita i 
neurona te istražiti utjecaj hiposksije na interakciju astrocita i neurona. 
Metode: Primarni astrociti izolirani su iz novorođenih miševa, dok su živčane matične 
stanice izolirane iz embrija miševa starih 14.5 dana. Astrociti i živčane matične stanice su 
nasađeni zajedno kako bi se dobila mješovita kultura, uzgajana u u normalnim uvjetima te u 
uvjetima hipoksije. Mješovite kulture su analizirane imunohistokemijski, praćena je 
mobilnost stanica i analizirana je ekspresija apoptotičkog (Casp8) i nekroptotičkog markera 
(Mlkl) metodom qRT-PCR.   
Rezultati: Karaterizacija mješovitih kultura u hipoksičnim uvjetima pokazala je da su se 
živčane matične stanice diferencirale u unipolarne i bipolarne neurone te je pokazana 
prisutnost plosnatih i elipsoidnih astrocita. Vrijednosti prosječne i maksimalne brzine stanica 
u mješovitim kulturama su bile veće u hipoksičnim uvjetima, ali manje od onih zabilježenih u 
kulturi samih živčanih matičnih stanica u normalnim uvjetima. Relativna ekspresija gena 
Casp8 bila je veća od ekspresije Mlkl i u hipoksičnim i normalnim uvjetima. 
Diskusija: U hipoksičnim uvjetima zabilježena je bolja diferencijacija i preživljenje živčanih 
matičnih stanica te bolja mobilnost stanica u kokulturi. Iako je zabilježena razlika u relativnoj 
ekspresiji gena Casp8 i Mlkl u normalnim i hipoksičnim uvjetima, za određivanje razine 
statističke značajnosti će biti potrebno imati veći broj bioloških replika. 
Zaključak: U mješovitoj kulturi astrocita i neurona smo opazili promjene koje se inače 
dešavaju u ishemiji. Potrebna su nova istraživanja na ovim stanicama koja će dovesti do 
boljeg razumijevanja interakcija prisutnih u hipoksiji. 
Ključne riječi: Astrociti, NSC (živčane matične stanice), kokultura astrocita i neurona, 
mobilnost stanica, Casp8, Mlkl, qRT-PCR. 
33. Introduction 
Stroke is the second most common cause of death in the world and one of the main causes of 
disability in adults. In 2013, there were 6.5 million deaths due to stroke, and with an overall 
cost of 113 million disability-adjusted life years (1) The burden of stroke due to illness, 
disability and early death is set to double worldwide within next 15 years due to rise in 
prevalence of vascular risk factors in developing countries (1). Stroke can be divided into two 
main types, ischaemic and haemorrhagic. Ischemic stroke accounts for 85% of strokes, and it 
results from vascular occlusion, due to atherosclerotic large artery disease, small artery 
disease (lacunar infarcts), or cardioembolic events (2). The treatments for ischemic stroke are 
neuroprotective, that target to prevent the brain damage due to vessel occlusion and 
neurorestorative, which aim to repair the brain damage after it has already been done.  
 
Within minutes after the blockage of an artery, the “necrotic core” develops where brain 
tissue is irreversibly damaged. The reversible damaged tissue “ischemic penumbra” around 
the necrotic core receives inadequate blood flow from the collateral bloody supply (3). The 
central goal of therapy in acute ischemic stroke today is to preserve tissue in the ischemic 
penumbra by restoring the blood flow to it before irreversible cell damage has occurred (4). 
Currently, the standard of care treatment in acute ischemic stroke is neuroprotective 
intravenous thrombolysis (IVT). In IVT, recombinant tissue-type plasminogen activator (rt-
PA) is intravenously administered in order to break down the blood clot and restore the blood 
flow to ischemic penumbra (5). Despite strong evidence that IVT improves outcomes in acute 
ischemic stroke, it has notable limitations of hemorrhagic transformation (6), narrow 
therapeutic time window of 4.5 to 6 hours (5), and ineffectiveness in lysing big clots (7). 
Further, due to contraindications of IVT, only up to 24% of acute ischemic patients can be 
eligible for IVT if treatment is not delayed (8). In last few years, multiple clinical trials have 
shown evidence in support of acute endovascular thrombectomy using stent-retriever for the 
treatment of acute ischemic stroke (9). However, it is also restricted to only a small portion of 
patients, due to contraindications, short therapeutic window and the costs associated with 
establishing the infrastructure to deliver this treatment (10).  
 
The cell death in ischemic stroke starts within few minutes after the vessel occlusion, 
longtime before the clot can be removed. One key mediator of cell death in ischemic stroke is 
excitotoxicity as a consequence of adenosine triphosphate (ATP) depletion and failure to 
4maintain membrane potentials. This results in excessive release of glutamate, which in turn 
leads to activation of ionotropic glutamatergic receptors (AMPA, Kainate and NMDA). The 
activation of these receptors leads to uncontrolled calcium entry which disrupts a vast variety 
of physiological processes, ultimately resulting in DNA, lipid and protein damage and 
eventually cell death (11). A number of neuroprotective agents targeting excitotoxicity have 
been tried to limit the cell death during an ischemic stroke. The NMDA antagonists targeted 
against excitotoxicity have failed to demonstrate benefits in patients (12). The animal studies 
have shown that targeting the downstream pathway of excitotoxicity can be of clinical 
importance. Coupling of activated subunit (NR2B) of NMDA receptor with death associated 
protein kinase1 (DAPK1), during excitotoxicity results in apoptosis. Inhibition of this 
coupling by a compound called NR2BCT or by interfering with p53 signaling pathway can 
reduce infarct size and improve neurological outcome in animal models (13, 14).  
 
A peptide called NA-1 is another example of neuroprotective therapy that targets downstream 
pathway of excitotoxicity. NA-1 works by inhibiting the coupling of NMDA receptor 
subunits (PSD)-96 and neuronal nitric oxide synthase (nNOS). This uncoupling of nNOS 
from activated glutamate receptor leads to decrease production of noxious nitric oxide (NO) 
during excitotoxicity (15). A study done in three non-human primate models of ischemic 
stroke demonstrated neuroprotective role of NA-1 (16). A multicentre, randomized, double 
blind, placebo-controlled, phase III clinical trial using pre-hospital administration of NA-1 in 
ischemic stroke is currently recruiting. The primary objective is to determine the efficacy of 
NA-1 in reducing global disability in patients with acute ischemic stroke. The secondary 
objectives are to determine the effectiveness of NA-1 in reducing functional dependence, 
improving neurological outcome, improving activities of daily living, and increasing the 
proportion of subjects who are candidates for endovascular recanalization therapy (17).  
 
The generation of free radicals, including reactive oxygen and nitrogen species (ROS/RNS), 
during ischemia is another key step to cell death in brain during an ischemic injury (18). Pre-
clinical studies showed that limiting the production of these free radicals could have 
neuroprotective effect in decreasing the brain damage due to ischemic-reperfusion injury 
(15). Though, the results of these pre-clinical studies are yet to be translated into clinical 
practice. The clinical trials of NXY-059, a nitrogen free radical scavenger, and uric acid 
failed to demonstrate benefit in ischemic stroke patients (19, 20). Edaravone, another 
5scavenger compound, is clinically used in parts of Asia and meta-analyses of trials suggest it 
reduces neurological impairment; however, it is not used in Europe or America due to lack of 
clinical evidence from a large phase III trials in non-Asian populations (21).  
 
Due to short therapeutic window and unsuccessful clinical trials of neuroprotective therapies 
to minimise the tissue infraction, there is an increasing interest of current research to develop 
neurorestorative therapies for treating stroke after the damage has been done (22). 
Neurorestorative agents amplify endogenous brain repair mechanisms to repair damaged 
tissue. Neurorestorative therapies have the advantage of long therapeutic window and could 
be given as stand-alone or as an adjunct therapy to improve stroke outcome. Preclinical data 
indicate that cell-based and pharmacological therapies that enhance brain-repair processes 
substantially improve functional recovery when given 24 h or later after stroke (23). It is 
proposed that cell-based therapies, including mesenchymal cells, bone marrow cells and 
neuronal stem cells stimulate the production of restorative factors by endogenous 
parenchymal cells leading to enhancement of endogenous neurogenesis in brain after 
ischemia (24). A phase I clinical trial of allogenic neural stem cells (NSCs) in patients with 
chronic ischemic stroke has shown no adverse events and improved neurological functions 
(25). Neurorestorative therapies that targeted against inhibitors of neuronal growth such as 
myelin-associated glycoprotein, the Nogo family of proteins, and chondroitin sulphate 
proteoglycans in the glial scar did not show clinical benefit (26).  
 
While most of the research has been directed towards at preventing direct neuronal death or 
affecting neuronal repair, a considerable amount of damage caused to brain tissue after 
ischemic stroke is due to inflammation. The activation of the immune system after ischemic 
stroke has been described as a double-edged sword, with microglia actively removing dead 
cells but also producing toxic substances that potentially exacerbate damage (27). The 
protective role of microglia is associated with their activation in the absence of “off” signal 
from neurons via ligand-receptor interaction during ischemia that is usually present in normal 
conditions (28). On the other hand, toxic character of microglia is related to their activation 
by damage-associated molecular patterns (DAMPs) via toll-like receptors during ischemia 
(29). The therapeutic approaches that have targeted the reduction of toll-like receptor 
signalling are known to reduce lesion volume in ischemic animal models (30, 31). The results 
of a clinical trial showed that oral administration of minocyclin, a second-generation 
6tetracycline, within 6 to 24 hours after acute ischemic stroke for 5 days significantly 
improved stroke outcome (32). The mechanism of minocycline induced neurorestorative 
effect is related to reduction of inflammation induced by activated microglia (33).  
 
Astrocytes are the most abundant cell type in mammalian brain and play a major role in 
brain’s response to all types of injuries including ischemic stroke. In the setting of ischemia, 
astrocytes perform multiple functions, some beneficial and some potentially detrimental. The 
astrocyte syncytium provides a network of communication channels called gap junctions 
throughout the brain. Following ischemic stroke, the gap junctions remain open allowing 
propagation of damaging spreading depression (34).  Activated astrocytes also produce 
proinflammatory cytokines, which can be detrimental to ischemic recovery by inducing 
apoptosis of neuronal cells (35). The reactive astrocytes form a glial scar around the infract 
area over many weeks after the injury, and studies have established that the glial scar helps to 
provide a barrier to localise the damage within the brain, but in doing so it also becomes a 
physical and chemical barrier for axonal regeneration (36).  
 
Astrocytes support neurons during ischemic injury by providing antioxidant protection, 
substrates for neuronal metabolism, growth factors and glutamate clearance (37). The 
neurons die in ischemic penumbra when native astrocytes undergo programmed cell death or 
become malfunctioning leading due delayed expansion of the evolving infarct (37, 38). 
Therefore, many recent efforts have focused on the astrocyte-neuron interaction and how 
astrocyte function can be improved after stroke to enhance neuronal support and survival (39, 
40). A detailed understanding of astrocyte-neuron interaction can provide valuable 
therapeutic targets to develop both neuroprotective and neurorestorative treatments for 
ischemic stroke patients. The use of co-cultures in in vitro model, where astrocytes and 
neurons are grown together allowing physical contact between each other, constitute valuable 
tool to study the interaction between cell populations. An in vitro model of cell cultures has 
the advantage of controllability and ability to provide detailed basic information on how a 
particular cell population responds to specific stimuli or insult (41).  
 
4. Hypothesis of the study 
In vitro model of astroglial-neuronal co-cultures will allow to obtain detailed insight in the 
processes occurring in the nervous tissue in regard to normoxic and hypoxic conditions. 
75. Objectives of the study 
The aim of this study was to develop an in vitro model of astroglial and neuronal co-cultures, 
which can then be utilized to study the interaction between astrocytes and neurons during 
normoxic and hypoxic conditions:  
	  
5.1 Qualitative data: To illustrate neuronal differentiation of NSCs to neurons with neuronal 
differentiation medium, and to characterise astroglial and neuronal co-cultures in hypoxic 
conditions using immunohistochemistry and live-cell imaging. 
5.2 Quantitative data: To quantify locomotion of cells in astroglial and neuronal co-cultures 
during normoxic and hypoxic conditions using live-cell imaging and cell tracking software. 
To determine if apoptosis or necroptosis is the main process of cell death in astroglial-
neuronal co-cultures due to hypoxia by measuring relative gene expression of apoptotic 
(caspase 8) and necroptotic marker (MLKL) with rt-PCR. 
6. Experiment design 
Primary astrocytes were obtained from cerebral cortices of newborns and NSCs were isolated 
from telencephalon wall of E14.5 and E15.5 mouse embryos. Neurons were developed from 
NSCs by adding neuronal differentiation medium. Astrocytes and NSCs were seeded together 
with astrocyte growth medium and neuronal differentiation medium to create astroglial-
neuronal co-cultures. Controls and co-cultures were incubated in normoxic and hypoxic 
conditions. Subsequently live-cell imagining, immunocytochemistry, cell tracking and rt-
PCR were performed to obtain data. Figure 1 shows the experiment design in detail.  
 
 
 
 
 
 
 
 
Figure 1: Schematic diagram of experiment design of this study.  
87. Materials and Methods 
7.1. Primary astrocytes cultures  
Primary astrocytes were isolated from the cerebral cortices of six newborn pups of mouse 
strain B6.Cgp-Tg (Thy1-YFP) 16Jrs/J. Briefly, the heads of embryos were decapitated at the 
level of cervical spine and submerged in 70% ethanol for disinfection.  The decapitated heads 
were taken out of ethanol and placed in petri dishes containing 1x phosphate buffered saline 
(PBS). The brains were exposed after removing the skin and cranium. The cerebral cortices 
were isolated from exposed brains after removing the meninges and white matter.  The 
cerebral cortices were chopped into small pieces, and pooled together in 50ml falcon tube.  
The warm 0.1% trypsin was added to the pooled cortices and incubated in 37 0C for 20 
minutes, and mechanical dissociation of the cerebral cortices was performed to reach the 
homogenous fluid. The warm DMEM/F-12, to stop the action of trypsin, was added to 
homogenous fluid containing cells and trypsin, and centrifuged at 400 x g for 6 minutes at 
room temperature. After discarding the supernatant, the pallet of cells was re-suspended and 
dissociated in astrocyte cell culture medium (DMEM/F-12 supplemented with 10% fetal 
bovine serum (FBS) and 1% penicillin/streptomycin). The cells with culture medium were 
transferred to 75 cm2 flask and placed in a 37 0C incubator at 5 % CO2. The metabolic activity 
of astrocytes is higher compared to other cell types such as microglia; therefore, in 
nutritionally deprived conditions astrocytes show low survival rate while microglia is not 
affected by nutritional deprivation and proliferate in such conditions (42). Further, astrocytes 
tend to attach to surface of flask and grow as monolayer, while the microglia grow freely on 
top of the astrocytic cell monolayer (43). To maintain low number of microglial cells in 
astroglial cultures, the astrocyte culture medium was changed every 3 days to prevent 
nutritional deprivation conditions and to remove free growing microglia. The cells were 
grown to confluence before seeding. 
7.2. Neuronal stem cells (NSCs) cultures 
Neuronal stem cells (NSCs) were isolated from telencephalon wall of E14.5 and E15.5 
embryos of mouse stain B6.Cgp-Tg (Thy1-YFP) 16Jrs/J. Briefly, the pregnant females were 
euthanized with cervical dislocation. Following the disinfection of abdominal area with 70% 
alcohol, uterus was surgically removed and placed in cold PBS. The embryos were removed 
from the uterus and placed in a Petri dish with cold PBS.  The heads of embryos were severed 
at the level of cervical spine, and cerebral cortices were isolated while white matter and 
meninges were removed. The cortices were chopped into small pieces and pooled together in 
950ml falcon tube. The warm accutase was added to the pooled cortices and incubated in 37 
0C for 20 minutes. The cortices were mechanically dissociated well to obtain turbid fluid. The 
warm DMEM/F-12 was added and centrifuged at 400 x g for 6 minutes at room temperature. 
The pallet containing cells was re-suspended and dissociated in full NSC medium (DMEM/F-
12 supplemented with 2% B27, 2% N2, 1% penicillin/streptomycin, and 20ng/ml final 
concentration of each; fibroblast growth factor (FGF-2) and epidermal growth factor (EGF)).  
The cells with full NSC medium were transferred to 75 cm2 flasks and placed in a 37 oC 
incubator at 5 % CO2.  
7.3. Cells cultivation and seeding  
NSCs with neuronal differentiation growth medium were seeded in 24 well plate pre-coated 
with polydellisine (PDL) and laminine in normoxic and hypoxic conditions for live-cell 
imaging. Astrocytes and astroglial-neuronal co-cultures were grown on PDL and laminine 
coated glass coverslips placed in the 24 well plates in normoxic and hypoxic conditions for 
live-cell imaging and immunocytochemistry. To measure gene expression using rt-PCR, 
astroglial and neuronal co-cultures were seeded in 6 well plates, in both normoxic and 
hypoxic conditions.  
 
Coating of glass coverslips with PDL and laminine: Glass coverslips were placed in a petri 
dish, and HNO3 added. The petri dish was wrapped with aluminum foil and left overnight on 
the shaker (30 rpm) at room temperature. The next day, HNO3 was removed and coverslips 
were rinsed with sterilized water for 2 hours at room temperature on the shaker. Then 
coverslips were rinsed in 70% ethanol at room temperature and left on the shaker for 
overnight. Following day, ethanol was removed and the petri dish with coverslips was placed 
at 250 0C for 8 hours. The sterilized coverslips were placed carefully in 24-well plate, each 
per well. Prepared solution of PDL (Ploy-D-lysine hydrobromide, 5mg/50 ml P6407-5MG, 
Sigma) was added over the surface of sterilized coverslip in each well and incubated 
overnight at room temperature in the cell culture hood. Next day, PDL solution was aspirated 
and coverslips were washed 3 times by sterilized water. Then prepared solution of laminine 
(1mg/ml Catalyst L2020-1MG, Sigma) was added to coverslips at +4 0C for overnight. 
Before the cell seeding, laminine was aspirated from each well and coverslips were washed 2 
times with 1x PBS.  
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Astrocytes cultivation and seeding: Primary astrocytes cultures were used to seed 
astrocytes. Astrocytes were cultivated by adding 0.1% warm trypsin in 75cm2 flask 
containing astrocytes after removing the culture medium from it. Trypsin was added for cell 
detachment from the surface of flask. Warm DMEM was added to stop the reaction of 
trypsin. Cells along with trypsin and DMEM were collected in a falcon tube and spun at 400g 
for 6 minutes. After removing the supernatant, the cell pellet was dissociated in full astrocytic 
culture medium (DMEM/F-12 supplemented with 10% FBS and 1% penicillin/streptomycin). 
The cell density was determined by staining cells in tryptan blue and counting with cytometer 
under the light microscope. Approximately, 50,000 cells per well were seeded with full 
astrocyte culture medium.  
NSCs cultivation and neurons seeding: NSCs cultures grown to neurospheres were used to 
seed neurons. NSCs were cultivated from neurospheres by adding warm accutase. Accutase 
was added to dissociate the neurospheres. Warm DMEM was added to stop the reaction of 
accutase. Cells, accutase and DMEM were collected in a falcon tube and spun at 400g for 6 
minutes.  The supernatant was discarded and cell pallet was suspended in neuronal 
differentiation medium (DMEM/F-12 supplemented with 2% B27, 2% N2, 1% 
penicillin/streptomycin). The lack of growth factors (FGF-2 and EGF) in growth medium 
causes differentiation of NSCs into neurons. The cell density was determined by staining the 
cells in tryptan blue and counting with cytometer under the light microscope. Approximately, 
50,000 cells were seeded per well with neuronal differentiation medium.  
Astroglial and neuronal co-cultures seeding: To create astroglial and neuronal co-cultures, 
astrocytes and NSCs were cultivated from primary astrocytes culture and primary NSCs 
culture as described above.  First astrocytes were seeded and allowed to attach to the surface 
for few hours. Then NSCs were seeded in the same well. Each cell types were seeded with 
approximately 50,000 cells per well. The growth medium for astrocytes (DMEM/F-12) with 
10% FBS and 1% penicillin/streptomycin) and neuronal differentiation medium (DMEM/F-
12 supplemented with 2% B27, 2% N2, 1% penicillin/streptomycin) were added in each well 
in 50/50 ratio.  
7.4. Live-cell imaging and live-cell tracing 
Astrocytes, NSCs-neurons, astroglial and neuronal co-cultures were incubated in the cell 
chamber of EVOS FL Auto Cell Imaging System from Thermo Fisher Scientific for live 
imaging. The conditions for cells were normoxic (21% O2) and hypoxic (5% O2), both at 37 
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0C in 5% CO2. The cells were placed in these conditions for 72 hours (Day 0, 1, 2) and live 
images were taken at 20x magnification for every 7 minutes at different beacons for each 
condition. The live images were made into stacks by using ImageJ. The stacks were used to 
track the cells with software called CellTracker written in MatLab 2012. The data was 
obtained from the CellTracker software about parameters (maximum speed, average speed 
and average angle of direction from origin) of locomotion of cells.  Statistics were performed 
on the results acquired from the CellTracker using GraphPad Prism.  
7.5. Immunocytochemistry 
The cells used in the immunocytochemistry assays were cultured in 24 well plates containing 
coverslips previously coated with PDL and laminine. After removing the culture medium, the 
cells were rinsed with 1x PBS and fixed in 4% paraformaldehyde for 10 min at room 
temperature. For blocking non-specific antibody binding and cell permeabilization, cells were 
incubated with blocking buffer (3 % bovine serum albumin (BSA), 3% donkey serum 
albumin (DSA) in 1x PBS) and 0.2% triton x-100 combined with blocking buffer for 3 hours 
at room temperature. The cells were incubated overnight at 4 °C with anti-glial fibrillary 
acidic protein (chicken anti-GFAP; 1:250; ab4674), anti-microtubule-associated protein 2 
(chicken anti-MAP2; 1:1000; ab5392), anti-antigen Ki67 (rabbit anti-Ki67; 1:250; ab15580), 
anti-nestin (goat anti-nestin; 1:500; sc-21248) and anti-CD11b (rabbit anti-CD11b; 
1:300&1:500; ab133357) diluted in blocking buffer and 0.2% triton x-100. The neuronal-
astroglial co-cultures and astrocytic cultures, both in normoxia and hypoxia, were stained 
with combinations of GFAP+Ki67, MAP-2+Ki67, nestin+Ki67, nestin+GFAP and 
nestin+MAP. The astrocytic cultures in normoxia conditions were also stained with 
CD11b+GFAP to examine the presence of microglia. After removing the primary antibodies, 
cells were washed 3x5min with PBS. Then cells were incubated with secondary antibodies: 
goat-anti-chicken conjugated to Alexa Fluor 546 (1:1000; A11040), donkey-anti-goat 
conjugated with Alexa Fluor 546 (1:1000; A11056), donkey-anti-rabbit conjugated with 
Alexa Fluor 488(1:1000; A21206) and donkey-anti-goat conjugated to Alexa Fluor 488 
(1:1000; A11055) diluted in 1x PBS for 1 hour at room temperature. After removing the 
secondary antibodies, the cells were washed 3x5min with 1x PBS and incubated for 10 min 
with nuclear marker, Hoechst/Dapi (1:8000; Roche; 10236276001) diluted in 1x PBS. After 
removing the nuclear marker, the cells were washed again 3x5min with 1x PBS. The cover 
slip containing stained cells was removed from the 24 wells plate, and mounted onto glass 
slide in Dako fluorescence mounting medium. Images were acquired using EVOS FL Auto 
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Cell Imaging System with 40x objective. Images were processed by software called ImageJ.  
7.6. RNA isolation for real time-PCR 
RNA was isolated from astroglial-neuronal co-cultures incubated in normoxic and hypoxic 
conditions for 5 days. The protocol was adapted from the one provided with the RNeasy mini 
kit (Qiagen, cat no. 74104). Briefly, the cell culture medium was removed and the cells were 
washed with 1x PBS. The RLT buffer was added in each well, which lysed the cells and 
released RNA. The RLT buffer also inactivated RNase to ensure purification of intact RNA. 
The lysed cells were scraped off from surface of the plate by the cell scraper, and collected in 
small Eppendorf tubes. The collected cells were spin at 14000 x g for 3 minutes, and 70% 
ethanol was added. The centrifuged cells with ethanol were transferred to RNeasy spin 
columns placed in a 2ml collection tube, and spun 2x for 15 seconds. The mRNA specifically 
bound to the silica-based membrane in spin columns and contaminants were discarded which 
flow through into collection tube. The RW1 and RPE buffer were respectively added into 
spin columns and centrifuged for 15 seconds. The centrifugation was performed for 2 
minutes with RPE buffer and for 1 minute without any buffer to ensure that no ethanol and 
buffer was carried over during RNA elution. The flow through from these centrifugations 
was discarded. The RNeasy spin columns were transferred into new 1.5 ml collection tubes. 
The RNase-free water was added directly to the spin columns membrane and centrifuged for 
1 minute at 14000 rpm to elute the RNA. The RNA containing flow through was added again 
into the RNeasy spin columns membranes and centrifuged for one minutes at 14000g. The 
mRNA sample in the collected tubes was stored in -80 0C.   
7.7. Real time-polymerase chain reaction   
RNA was reverse transcribed into cDNA using a commercially available kit: a high capacity 
RNA-to-cDNA Kit (Applied Biosystems, 850 Lincoln Center Drive, Foster City, CA 94404, 
USA) according to the manufacturer's instructions and 27020 Thermal Cycler (Applied 
Biosystems ) (44). The essays used in this study were Caspase 8 (Mm01255716_m1) and 
Mlkl (Mm01244222_m1) (TaqMan Gene Expression Assays), and gene expression was 
analyzed with respect to the endogenous control of beta-actin (ACTB MGB 4352933E) 
(TaqMan Gene Expression Assays). All samples were made in duplicates with 1 μg of cDNA 
in a total volume of 20 μL, and the chain reaction in real time was made according to the 
manufacturer's instructions and in the Applied Biosystems 7500 Real-Time PCR System.  
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The Applied Biosystems ™ TaqMan® Real-Time PCR Exercise is based on following 
mechanism. The essays contain: a pair of unlabeled primers specific to the genome and 
probes with FAM ™ or VIC ™ fluorogenic colors at the 5 'end, while at the 3' end of the 
small groove binder molecule (MGB) and a non-fluorescent molecule that captures the signal 
of a nonfluorescent quencher (NFQ). At the beginning of the polymerase chain reaction in 
real time, the temperature was raised to denature the double-stranded cDNA. During the first 
step, the fluorescence signal at the 5 'end of the NFQ probe is captured at the 3' end and the 
signal can not be detected. In the next step, the reaction temperature is lowered to allow 
initiation and probe binding to complementary sequences in the cDNA. Taq DNA 
polymerase synthesizes new DNA lancing using uninitiated primers. When the polymerase 
reaches the labeled probe, its endogenous 5 'nuclease activity breaks down the test by 
separating the color of the molecule that captures the color signal. With each cycle of 
polymerase chain reaction, more and more colors are released which results in an increase in 
the fluorescence intensity proportional to the synthesized amplicon.  
 
The device measures the intensity of the fluorescence in each cycle whereby the so-called 
amplification curve is generated. At the amplification curve there is a threshold value, which 
is the value of the intensity of the fluorescence on which the signal obtained by amplification 
of the desired gene increases the initial noise. For the gene expression analysis, the number of 
cycles (CTs) that is found in the amplification curve between the signal boundary limit and 
the platinum that occurs when the reagents are consumed, i.e., there is no more amplification 
of the gene, so the fluorescence intensity is constant. The gene expression analysis was 
performed in such a way that the CT value of the endogenous control (beta actin) was 
deduced from the CT value for a given gene and a ΔCT value was obtained. Relative 
expression of the gene was obtained by the formula 2- ΔCT. 
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8. Results 
8.1. Characterization of neuronal differentiation of neural stem cells in normoxia   
Images taken right after seeding of NSCs in normoxic conditions revealed that cells exhibit  
different morphology which were consistent with undifferentiated neuronal stem cells and 
neuronal progenitor cells with round and bi-polpar shape, respectively (Figure 2). Due to 
neuoronal differetiation medium, images taken 24 hours post-seeding showed the 
differentiation of NSCs into neurons with bi-polar and uni-polar morphology. Pyknotic cells 
with condensed nuclie can also be seeen after 24h post-seeding of NSCs (Figure 3).  
 
 
 
 
 
 
 
 
8.2. Characterization of neuronal differentiation of neural stem cells in hypoxia  
Immediately after seeding of NSCs in hypoxic conditions, images showed similar 
morphology of undifferentiated NSCs and progenitor cells as seen in normoxic conditions 
(Figure 4). At 24h post seeding, we observed neuronal differentiation: neurons with bi-polar 
and uni-polar morphology were seen. We observed more pyknotic cells in hypoxic conditions 
as compared to normoxic conditions (Figure 5).  
 
 
 
 
 
 
Figure 2: Image was taken 0h after seeding of
NSCs in normoxic conditions. Cells with 
undifferentiated morphology of NSCs and 
neuronal progenitor cells can be seen.   
Figure 3: Image was taken 24h after seeding of
NSCs in normoxic conditions. Yellow, red and 
green arrows show neurons with bi-polar and uni-
polar morphology and pyknotic cells respectively.  
Figure 4: 0h after seeding of NSCs in hypoxic 
conditions. A neuropshere can be seen.  
Figure 5: 24h after seeding of NSCs in hypoxic
conditions. Neuronal differentiation was present.  
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8.3. Characterization of astroglial-neuronal co-cultures in hypoxia 
Image taken after seeding of NSCs and astrocytes to create astroglial-neuronal co-cultures 
showed immature astrocytes attached to the surface and NSCs with round shape consistent 
with undifferentiated morphology (Figure 6). After 24h post seeding, astrocytes started to 
grow to confluence with flatter morphology and the physical contact between them was 
observed. There was also neuronal differentiation occurring, but it was less robust as 
compared to NSCs grown alone as seen in figure 3 and 5. There was physical contact 
between neurons and astrocytes. There were few pyknotic cells seen at 24h in astroglial-
neuronal co-cultures (Figure 7).  
 
 
 
 
 
 
\ 
Immunocytochemical images of astroglial-neuronal co-cultures after exposure to hypoxic 
conditions demonstrated presence of GFAP positive astrocytes and nestin positive cells 
(Figure 8 & 9). The morphology of astrocytes was broad and there were no elongated 
processes. There were also cells present positive for both nestin and Ki67, which 
demonstrated presence of dividing cells in hypoxic conditions (Figure 10).  
 
 
 
 
 
 
 
Figure 6: Image of astroglial-neuronal co-cultures 
at 0h after exposure to hypoxic conditions. 
Immature astrocytes (red arrow) and NSCs and
neuronal progenitor cells were present.  
Figure 7: Image of astroglial-neuronal co-cultures 
at 24h after exposure to hypoxic conditions. There
was physical contact between astrocytes-
astrocytes and astrocytes-neurons.  
Figure 8: GFAP immunostaining
showing astrocytes in co-cultures 
in hypoxic conditions. DAPI
(blue) staining shows nuclei. 
Figure 9: Nestin immunostaining
showing NSCs in co-cultures in
hypoxic conditions. DAPI (blue)
staining shows nuclei. 
 
Figure 10: Nestin immunostaining
showing NSCs and presence of
Ki67 positive cells  (red arrow) in
co-cultures in hypoxic conditions.  
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Statistical analysis of locomotion parameters: Nonparametric Kruskal-wallis and post-hoc 
Dunn’s test for multiple comparisons were performed for maximum speed, average speed and 
average angle of direction from origin. For all the tests, p<0.05 was considered significant.  
Comparison between 
different conditions 
Maximum speed 
Significant? 
p <0.05 
Average speed 
Significant? 
p <0.05 
Average angle of 
direction from origin 
Significant? 
p <0.05 
NSCs normoxia day 0 vs. 
NSCs hypoxia day 0 + + - 
NSCs normoxia day 0 vs. 
Co-cultures normoxia day 0 + + - 
NSCs normoxia day 0 vs. 
Co-cultures hypoxia day 0 - + - 
NSCs normoxia day 1 vs. 
Co-cultures normoxia day 1 + + - 
NSCs normoxia day 1 vs. 
Co-cultures hypoxia day 1 + + - 
NSCs normoxia day 2 vs. 
Co-cultures normoxia day 2 + + + 
NSCs normoxia day 2 vs. 
Co-cultures hypoxia day 2 + + - 
Co-cultures normoxia day 0 vs. 
NSCs hypoxia day 0 - + - 
Co-cultures normoxia day 0 vs. 
Co-cultures hypoxia day 0 + + - 
Co-cultures normoxia day 1 vs. 
Co-cultures hypoxia day 1 + +                   - 
Co-cultures normoxia day 2 vs. 
Co-cultures hypoxia day 2 + + - 
Co-cultures hypoxia day 0 vs. 
NSCs hypoxia day 0 + - - 
Comparison within each 
condition    
NSCs normoxia day 0 vs. 
NSCs normoxia day 1 - - - 
NSCs normoxia day 0 vs. 
NSCs normoxia day 2 - - - 
NSCs normoxia day 1 vs. 
NSCs normoxia day 2 - - - 
Co-cultures normoxia day 0 vs. 
Co-cultures normoxia day 1 + + + 
Co-cultures normoxia day 0 vs. 
Co-cultures normoxia day 2 + + + 
Co-cultures normoxia day 1 vs. 
Co-cultures normoxia day 2 - - - 
Co-cultures hypoxia day 0 vs. Co-
cultures hypoxia day 1 + + - 
Co-cultures hypoxia day 0 vs. Co-
cultures hypoxia day 2 + + - 
Co-cultures hypoxia day 1 vs. Co-
cultures hypoxia day 2 -                - - 
 
8.5. Gene expression of caspase 8 and MLKL in astroglial-neuronal co-cultures 
Table 1: Results of post-hoc Dunn’s test for multiple comparisons. There was significant difference 
between maximum and average speed among different groups and within each group for different days 
as om r d to average angle of direction from o igin.  
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8.5. Relative expression of caspase 8 and MLKL in astroglial-neuronal co-cultures in 
normoxia and hypoxia 
The relative expression of caspase 8 and MLKL in astroglial-neuronal co-cultures in both 
normoxic and hypoxic conditions is presented in graph 7. The results showed expression of 
both genes in co-cultures in both normoxic and hypoxic conditions. There was tendency of 
higher expression of caspase 8 in both conditions, and it was also inclined to express more in 
normoxic conditions as compared to hypoxic conditions. On the other hand, co-cultures in 
hypoxic conditions had slight predisposition to express more MLKL as compared to 
normoxic conditions.   
 
 
 
 
 
 
 
 
9. Discussion  
In the present study, a valuable culture method was provided to obtain astroglial-neuronal co-
cultures from primary astrocytes and NSCs. It is critical to obtain pure primary astrocytes 
cultures with minimum contamination with other cells. The cortices of newborn pups have 
other cells such as microglia, oligodendrocytes and fibroblasts, which could grow in primary 
astrocytes cultures. This could prevent to have appropriate astroglial-neuronal co-cultures to 
study interaction of astrocytes and neurons. The method used in this study to isolate primary 
astrocytes has shown good results in previous studies to obtain pure astrocyte cultures with 
minimum cellular contamination (45). Astrocytes tend to attach to surface of flask and grow 
as monolayer, while the microglia grow freely on top of the astrocytes (43). Neurons die 
early due to lack of appropriate growth medium. Thus microglia, oligodendrocytes precursor 
cells (OPCs) and dead neurons in primary astrocytes culture were reduced with tapping the 
flasks and changing the culture medium after every three days. To further decrease cellular 
contamination in primary astrocytes culture, use of anti-mitotic compound called arabinose 
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Graph 7: Relative expression of caspase 8 and MLKL in astroglial-neuronal co-cultures 
in normoxic and hypoxic conditions.  
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cytosine (Ara-C) is reported to have good results (46). It reduces the rapidly dividing cells 
such as microglia and fibroblasts (47, 48). The astrocytes culture purity was confirmed with 
immunostaning GFAP for astrocytes. Non-GFAP positive cells can be quantified and 
contaminants can be estimated. This methodology does not identify presence of specific cells, 
but it is a faster and more economic method to determine the percentage of non-astrocytic 
cells in the culture. Alternatively, purity of astsrocytic cultures can be confirmed with 
immunostaining selective markers for the most prominent cell contaminants. For instance, 
antibodies against ionized calcium binding adaptor molecule (Iba-1), olig2 and vimentin can 
be used to detect microglia, OPCs and fibroblasts respectively (45).  
 
The neuronal differentiation of NSCs was well observed in both only NSCs cultures and in 
astroglial-neuronal co-cultures with neuronal differentiation medium. The presence of EGF 
and FGF-2 are important to keep pluripotency of NSCs; thus, neuronal differentiation was 
seen after removal of these growth factors from full NSCs culture medium (49). Neurons 
with unipolar and bipolar morphology were present after 24 hours of seeding in both 
normoxic and hypoxic conditions. The neurons with this type of morphology are known to be 
sensory neurons.  
 
Pyknosis, irreversible condensation of chromatin in the nucleus of a cell undergoing necrosis 
or apoptosis, was observed in NSC-neurons cultures in both normoxic and hypoxic 
conditions. It could be interesting to perform cell viability assay on NSCs cultures in both 
hypoxic and normoxic conditions to compare cell viability in these conditions. NSCs exist 
with in “physiological hypoxic” conditions at 1 to 5% O2 in both embryonic and adult brains 
(50). Studies have shown that hypoxia promote the proliferation and differentiation of NSCs 
along with their survival in vitro and in vivo (50, 51). It is proposed that the mechanism of 
these responses might be primarily due to involvement of hypoxic inducible factor-1 (HIF-1) 
signaling pathway (50). HIF-1 when stabilized by hypoxic conditions, up regulates several 
genes to promote cell survival in low oxygen.  
 
The astroglial-neuronal co-cultures in hypoxic conditions were assessed by 
immunocytochemistry. GFAP, nestin staining showed presence of astrocytes and NSCs 
respectively in co-cultures. Ki67 and nestin positive cells demonstrated presence of dividing 
NSCs. There was differentiation of NSCs to neurons; however, it was less robust then NSCs 
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single cultures. Studies have demonstrated that the molecules secreted from activated 
astrocytes increase proliferation and differentiation of NSCs (52). However, astrocytes in co-
cultures were flat and epitheloid that resemble of immature astrocytes as compared to mature 
astrocytes that undergo hypertrophy and increased expression of GFAP in response to 
hypoxic condition (53). The presence of immature astrocytes in astroglial-neuronal co-
cultures could be due to growth factors released by NSCs or there was differentiation of 
NSCs into immature astrocytes due to presence of fetal bovine serum in culture medium. The 
physical contact between astrocytes themselves and with neurons and NSCs was present. 
There was presence of syncytia between astrocytes. In vivo astrocytes form syncytia with 
other astrocytes and create highly intricate networks between several types of cells, including 
endothelial cells and neurons. This highly complex 3D network is not possible to mimic in 
vitro due to different morphology of astrocytes in vitro as compared to in vivo (54).  
 
The quantification of locomotive parameters demonstrated superior cellular motility in 
astroglial-neuronal co-cultures in hypoxic conditions as compared to normoxic conditions in 
co-cultures and NSCs alone cultures. However, the highest cellular motility was of NSCs 
alone cultures in normoxic conditions.  Cellular motility is dynamic process that is primarily 
driven by actin network beneath the cell membrane. The cellular motility observed in this 
study was of crawling type, which consisted of three components; protrusion of the leading 
edge, deadhesion of the cell body and cytoskeletal contraction to pull the cell forward (55). 
Cell motility is essential to variety of biological processes such as migration of the cells to 
the injury area. Studies have shown that in response to hypoxic-ischemic injury, NSCs 
migrates preferentially to the injury site and differentiate into neurons (56).  
 
The better cellular motility in astroglial-neuronal co-cultures in hypoxic conditions as 
compared to in normoxic conditions could be due to changes in gene expression due to 
hypoxia. Hypoxia is shown to improve survival and growth of NSCs (51). Astrocytes also 
play an important role in guidance and support of neuronal migration during development 
and in response to injury (57). This was also observed in this study that there was tendency of 
higher average angle of direction from origin in astroglial-neuronal co-cultures as compared 
to single cultures. The higher average angle of direction from origin correlates with the 
movement towards a stimuli or chemoattractants.  It is known that astrocytes release 
neurotrophic factors that act as chemoattractants for neuronal migration in response to injury 
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(57). The motility of NSCs is also important for transplantation therapy to repair damaged 
brain tissue. The transplanted NSCs preferentially migrate to the area of injury and 
differentiate into neurons (56). Thus, astroglial-neuronal co-cultures could provide a valuable 
tool to study the motility of NSCs and neurons as it incorporates affect of astrocytes, which is 
also present in vivo.  
 
Necroptosis is a programmed form of necrotic cell death in caspase-independent fashion with 
leakage of cellular contents as compared to apoptosis, which is caspase-dependent, 
programmed cell death with no spilling of cellular contents. In necroptosis, the process of cell 
membrane permeabilization is tightly regulated that results in formation of necrosome via 
TNFa receptor signaling pathway. Necrosome then phosphorylates MLKL, which then insert 
into and permeabilize plasma membrane and organelles leading to leakage of cellular 
contents into the extracellular space (58). Necroptosis has been implicated in the pathology of 
ischemia-reperfusion injury in stroke and myocardial infarction (59).   
 
The measurement of relative gene expression of apoptotic marker (caspase 8) and necroptosis 
marker (MLKL) revealed that process of apoptosis was higher than necroptosis in astroglial-
neuronal co-cultures in normoxic and hypoxic conditions. There was tendency of low 
expression of caspase 8 in hypoxic conditions as compared to normoxic conditions. This 
could be due to protective affect of hypoxia on NSCs through HIFs).  The slight higher 
inclination of necroptosis in hypoxic conditions as compared to normoxic conditions could be 
due to lack of energy in hypoxic conditions preferring less energy consuming process of 
necroptosis as compared to apoptosis. However, statistical analysis could not be performed 
on these differences in relative gene expression of caspase 8 and MLKL due to lack of NSCs 
and astrocytes in single cultures as biological controls. 
 
Studies have shown substantial interplay between the apoptosis and necroptosis pathways. At 
multiple stages of their respective signaling cascades, the two pathways can regulate each 
other. Caspase 8 prevents the necroptosis by inhibiting the formation of necrosome, which is 
required to activate MLKL. Conversely, caspase 8 can be inactivated through anti-apoptotic 
protein CFLIP (60). Thus, there is reciprocal relationship between apoptosis and necroptosis. 
This reciprocal relationship was also observed in this study where relative gene expression of 
caspase 8 was higher than MLKL in both conditions.  
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10. Conclusion 
Astrocytes have a substantial impact on the injury induced by an ischemic insult, thus 
suggesting that the crosstalk between glia and neurons is crucial to the neuronal protection in 
conditions of ischemia. This study helped to lay a foundation to develop an in vitro model of 
astroglial-neuronal co-cultures to study interaction of astrocytes and neurons in response to 
hypoxia.  It is crucial to characterize the purity of these co-cultures, which is important to the 
correct interpretation of the results obtained. Quantifying cellular motility in cultures 
provided valuable information about the affect of hypoxic or normoxic conditions on NSCs, 
neurons and astrocytes, and also the affect of these cells on each other. The measurement of 
relative gene expression of caspase 8 and MLKL in astroglial-neuronal co-cultures provided 
valuable information about apoptosis and necroptosis in normoxic and hypoxic conditions. 
Thus, astroglial-neuronal co-cultures have the potential to obtain information about 
expression of genes involving astrocytes and neurons that play vital role in pathogenesis of 
hypoxic injury during ischemic stroke.  
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